Carlsmed Statistics
Total Valuation
Carlsmed has a market cap or net worth of $477.38 million. The enterprise value is $418.96 million.
Important Dates
The last earnings date was Tuesday, November 10, 2026, after market close.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Carlsmed has 27.40 million shares outstanding. The number of shares has increased by 215.17% in one year.
| Current Share Class | 27.40M |
| Shares Outstanding | 27.40M |
| Shares Change (YoY) | +215.17% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 12.17% |
| Owned by Institutions (%) | 27.51% |
| Float | 15.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.65 |
| Forward PS | 4.56 |
| PB Ratio | 6.30 |
| P/TBV Ratio | 6.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.79, with a Debt / Equity ratio of 0.29.
| Current Ratio | 5.79 |
| Quick Ratio | 5.32 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.33 |
Financial Efficiency
Return on equity (ROE) is -43.95% and return on invested capital (ROIC) is -23.86%.
| Return on Equity (ROE) | -43.95% |
| Return on Assets (ROA) | -32.03% |
| Return on Invested Capital (ROIC) | -23.86% |
| Return on Capital Employed (ROCE) | -43.63% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $565,157 |
| Profits Per Employee | -$315,465 |
| Employee Count | 127 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 7.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +47.13% |
| 50-Day Moving Average | 15.20 |
| 200-Day Moving Average | 12.68 |
| Relative Strength Index (RSI) | 57.92 |
| Average Volume (20 Days) | 176,420 |
Short Selling Information
The latest short interest is 1.24 million, so 4.53% of the outstanding shares have been sold short.
| Short Interest | 1.24M |
| Short Previous Month | 1.09M |
| Short % of Shares Out | 4.53% |
| Short % of Float | 7.88% |
| Short Ratio (days to cover) | 15.13 |
Income Statement
In the last 12 months, Carlsmed had revenue of $71.78 million and -$40.06 million in losses. Loss per share was -$1.48.
| Revenue | 71.78M |
| Gross Profit | 55.24M |
| Operating Income | -42.33M |
| Pretax Income | -40.06M |
| Net Income | -40.06M |
| EBITDA | -41.88M |
| EBIT | -42.33M |
| Loss Per Share | -$1.48 |
Full Income Statement Balance Sheet
The company has $80.21 million in cash and $21.79 million in debt, with a net cash position of $58.42 million or $2.13 per share.
| Cash & Cash Equivalents | 80.21M |
| Total Debt | 21.79M |
| Net Cash | 58.42M |
| Net Cash Per Share | $2.13 |
| Equity (Book Value) | 75.67M |
| Book Value Per Share | 2.76 |
| Working Capital | 87.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$34.36 million and capital expenditures -$556,000, giving a free cash flow of -$34.92 million.
| Operating Cash Flow | -34.36M |
| Capital Expenditures | -556,000 |
| Depreciation & Amortization | 453,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -34.92M |
| FCF Per Share | -$1.27 |
Full Cash Flow Statement Margins
Gross margin is 76.96%, with operating and profit margins of -58.98% and -55.82%.
| Gross Margin | 76.96% |
| Operating Margin | -58.98% |
| Pretax Margin | -55.82% |
| Profit Margin | -55.82% |
| EBITDA Margin | -58.35% |
| EBIT Margin | -58.98% |
| FCF Margin | n/a |
Dividends & Yields
Carlsmed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -215.17% |
| Shareholder Yield | -215.17% |
| Earnings Yield | -8.51% |
| FCF Yield | -7.31% |
Analyst Forecast
The average price target for Carlsmed is $22.00, which is 26.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.00 |
| Price Target Difference | 26.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 45.14% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Carlsmed has an Altman Z-Score of 3.79 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.79 |
| Piotroski F-Score | 3 |